Novartis Cosentyx® Receives Positive CHMP Opinion for Non-Radiographic Axial Spondyloarthritis Treatment
According to a press release on Global Newswire, Novartis has received a positive opinion on Cosentyx® from the Committee for Medicinal Products for Human Use (CHMP). This positive opinion…